Tags:DiagnosticsDrugEnergyFoodFoodTechITScience
Oxford Immunotec is a global, high-growth diagnostics company focused on developing and commercializing proprietary assays for immunology and infectious disease. The Company's T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, U.K. and in Marlborough, MA. http://www.oxfordimmunotec.com/north-america/wp-content/uploads/sites/2/Disclaimer-V2.pdf
Location: United Kingdom, England, Abingdon
Member count: 201-500
Total raised: $54M
Founded date: 2001

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
18.06.2012-$28M-finsmes.co...
30.04.2010Series D$26M-finsmes.co...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
08.01.2021PerkinElme...PerkinElmer and Oxford Immunot...--wellington...
14.05.2015$475M fund...The University of Oxford has p...-Paul Sawer...venturebea...
14.05.2015$475M fund...We are excited to bring Transf...-Paul Sawer...venturebea...
18.06.2012Oxford Imm...Oxford Immunotec, a Oxford, UK...funding U...-finsmes.co...
18.06.2012Oxford Imm... OXFORD, ENGLAND, Medical dia...--vcnewsdail...
30.04.2010Oxford Imm...Oxford Immunotec Ltd., an Oxfo...UK USA v...-finsmes.co...
29.10.2007Life scien...Featured companies: Azaya Ther...--venturebea...
14.07.2006Cambridge ...Cambridge firm wins UK Bio Ent...--cambridgen...